Avacopan in Vasculitis: Uncommon but Severe Liver Risks



Liver enzyme elevations related to avacopan therapy are uncommon in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, although drug-induced liver injury may occur.
Medscape Medical News



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *